NewsBenzingaApotex Salute Q2 EPS rettificato $0,57 supera la stima di $0,42, vendite $852,900 milioni superano la stima di $828,594 milioni Apotex Salute Q2 EPS rettificato $0,57 supera la stima di $0,42, vendite $852,900 milioni superano la stima di $828,594 milioni Benzinga 2026.11.12 11:04 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3